« Return to News | CROs/Service Providers

Kendle Reports 50% Income Drop, Suspends Guidance for 2009

Thursday, August 6, 2009 08:04 AM

Kendle’s net income was cut almost 50% in the second quarter 2009 with income dropping to $3.2 million, or $0.21 per diluted share, compared with net income of $6.3 million, or $0.42 per diluted share in Q2 2008. Net revenues for the quarter were $107.4 million, down from $127 million during the same period last year.

The contract research organization also announced that it is suspending financial guidance for 2009 “due to a combination of factors” and will reassess its guidance policy in 2010. Kendle CEO Candace Kendle did not comment on the financial results when they were released Thursday night. Kendle’s shares rose nine cents to $11.96 in after hours trading.

Earlier this month, Kendle reorganized its executive suite and created the new role of chief administrative officer (CAO) to increase innovation, productivity and organizational efficiency, the company said. Kendle’s chief operating officer Christopher Bergen assumed the role of executive vice president and CAO, while former Quintiles executive Stephen Cutler, Ph.D., replaced Bergen as COO and senior vice president.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.